Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1967 2
1971 1
1974 2
1982 1
1986 1
1988 1
1990 1
1991 3
1995 1
2001 1
2004 1
2005 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2015 1
2016 2
2018 1
2019 5
2020 12
2021 15
2022 16
2023 11
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Cannon CP, et al. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3. N Engl J Med. 2015. PMID: 26039521 Free article. Clinical Trial.
Assessment of Recurrent Stroke Risk in Patients With a Carotid Web.
Guglielmi V, Compagne KCJ, Sarrami AH, Sluis WM, van den Berg LA, van der Sluijs PM, Mandell DM, van der Lugt A, Roos YBWEM, Majoie CBLM, Dippel DWJ, Emmer BJ, van Es ACGM, Coutinho JM; MR CLEAN trial and MR CLEAN Registry Investigators. Guglielmi V, et al. JAMA Neurol. 2021 Jul 1;78(7):826-833. doi: 10.1001/jamaneurol.2021.1101. JAMA Neurol. 2021. PMID: 33970205 Free PMC article. Clinical Trial.
Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.
Chalos V, Venema E, Mulder MJHL, Roozenbeek B, Steyerberg EW, Wermer MJH, Lycklama À Nijeholt GJ, van der Worp HB, Goyal M, Campbell BCV, Muir KW, Guillemin F, Bracard S, White P, Dávalos A, Jovin TG, Hill MD, Mitchell PJ, Demchuk AM, Saver JL, van der Lugt A, Brown S, Dippel DWJ, Lingsma HF; HERMES CollaboratorsMR CLEAN Registry Investigators. Chalos V, et al. JAMA Neurol. 2023 Jul 31;80(9):940-8. doi: 10.1001/jamaneurol.2023.2392. Online ahead of print. JAMA Neurol. 2023. PMID: 37523199 Free PMC article.
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.
LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, Wolff L, van Voorst H, Tolhuisen ML, Dippel DWJ, van der Lugt A, van Es ACGM, Boiten J, Lycklama À Nijeholt GJ, Keizer K, Gons RAR, Yo LSF, van Oostenbrugge RJ, van Zwam WH, Roozenbeek B, van der Worp HB, Lo RTH, van den Wijngaard IR, de Ridder IR, Costalat V, Arquizan C, Lemmens R, Demeestere J, Hofmeijer J, Martens JM, Schonewille WJ, Vos JA, Uyttenboogaart M, Bokkers RPH, van Tuijl JH, Kortman H, Schreuder FHBM, Boogaarts HD, de Laat KF, van Dijk LC, den Hertog HM, van Hasselt BAAM, Brouwers PJAM, Bulut T, Remmers MJM, van Norden A, Imani F, Rozeman AD, Elgersma OEH, Desfontaines P, Brisbois D, Samson Y, Clarençon F, Krietemeijer GM, Postma AA, van Doormaal PJ, van den Berg R, van der Hoorn A, Beenen LFM, Nieboer D, Lingsma HF, Emmer BJ, Coutinho JM, Majoie CBLM, Roos YBWEM; MR CLEAN–NO IV Investigators. LeCouffe NE, et al. N Engl J Med. 2021 Nov 11;385(20):1833-1844. doi: 10.1056/NEJMoa2107727. N Engl J Med. 2021. PMID: 34758251 Clinical Trial.
Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study.
Knapen RRMM, Pirson FAV, Langezaal LCM, Brouwer J, Majoie CBLM, Emmer BJ, Vos JA, van Doormaal PJ, Yoo AJ, Bruggeman AAE, Lycklama À Nijeholt GJ, van der Leij C, van Oostenbrugge RJ, van Zwam WH, Schonewille WJ; MR CLEAN Registry Investigators. Knapen RRMM, et al. Stroke. 2024 Feb;55(2):403-412. doi: 10.1161/STROKEAHA.123.043777. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174571 Free PMC article.
Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study.
van der Steen W, van der Ende NAM, van Kranendonk KR, Chalos V, van Oostenbrugge RJ, van Zwam WH, Roos YBWEM, van Doormaal PJ, van Es ACGM, Lingsma HF, Majoie CBLM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN Trial and MR CLEAN Registry Investigators. van der Steen W, et al. Stroke. 2022 Sep;53(9):2818-2827. doi: 10.1161/STROKEAHA.121.036195. Epub 2022 Jun 8. Stroke. 2022. PMID: 35674042 Free PMC article. Clinical Trial.
Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.
van Voorst H, Hoving JW, Koopman MS, Daems JD, Peerlings D, Buskens E, Lingsma H, Marquering HA, de Jong HWAM, Berkhemer OA, van Zwam WH, van Walderveen MAA, van den Wijngaard IR, Dippel DWJ, Yoo AJ, Campbell B, Kunz WG, Majoie CB, Emmer BJ; CLEOPATRA; MR CLEAN Registry; CONTRAST Consortium Investigators. van Voorst H, et al. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):515-527. doi: 10.1136/jnnp-2023-331862. J Neurol Neurosurg Psychiatry. 2024. PMID: 38124162
Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion.
Guglielmi V, LeCouffe NE, Zinkstok SM, Compagne KCJ, Eker R, Treurniet KM, Tolhuisen ML, van der Worp HB, Jansen IGH, van Oostenbrugge RJ, Marquering HA, Dippel DWJ, Emmer BJ, Majoie CBLM, Roos YBWEM, Coutinho JM; MR-CLEAN Registry Investigators. Guglielmi V, et al. Stroke. 2019 Dec;50(12):3360-3368. doi: 10.1161/STROKEAHA.119.026299. Epub 2019 Oct 29. Stroke. 2019. PMID: 31658903 Free PMC article.
Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
Huijberts I, Pinckaers FME, Olthuis SGH, van Kuijk SMJ, Postma AA, Boogaarts HD, Roos YBWEM, Majoie CBLM, van der Lugt A, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ; MR CLEAN-LATE investigators. Huijberts I, et al. Lancet Neurol. 2024 Sep;23(9):893-900. doi: 10.1016/S1474-4422(24)00228-X. Epub 2024 Jun 20. Lancet Neurol. 2024. PMID: 38909624 Clinical Trial.
75 results